← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Adient's revenue slipped, goodwill impairment drove a loss, and cash flow weakened.
The read at a glance✓ Audited against SEC data
- Growth — Revenue -1.0% to $14.54BWatch
- Profitability — Net income -1661.1% to -$281MWatch
- Cash quality — FCF -26.4% to $204MWatch
- Margins — Gross +29 bps; net -205 bpsNote
- Capital — $125M buybacks; no dividendNote
- Balance sheet — Debt -0.4%; equity -17.2%Watch
- Insiders — 0 buys / 2 sellsWatch
- Accounting — EQ 93.5 safe; goodwill CAMNote
Business
Adient is a global automotive seating supplier with positions in the Americas, EMEA, and Asia. It designs, engineers, manufactures, and delivers complete seat systems and components for passenger cars, commercial vehicles, and light trucks.
Where the revenue comes from
Fiscal 2025, as Adient plc reports it. History and quarterly detail are in the app.
- Americas$6.9B
- EMEA$4.8B
- Asia$3.0B
Leadership changes
From Adient plc's own filings, the day they're filed.
- J. Dorlack · President · appointmenteff. 2024-01-01
- Mark A. Oswald · principal financial officer of Adient at that time · appointmenteff. 2024-01-01
- Douglas G. Del Grosso · Chief Executive Officer · departureeff. 2023-12-31
Latest filings
- 8-K · Company announcement2026-08-21
- 8-K · Company announcement2026-08-13
- 8-K · Company announcement2026-08-05
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-07-10
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Adient plc, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.